Holliston, MA According to Performance Contracting, Inc. (PCI) New England, Andrew Collentro has joined the team as a business development manager, bringing decades of expertise in pharmaceutical critical utilities, process engineering, and strategic market growth.

Collentro has a distinguished career in the pharmaceutical industry. He has held key leadership roles at several organizations in the Life Sciences industry, where he drove business development, market analysis, and sales strategies for critical utilities and process systems. He has worked extensively with Architecture & Engineering firms, major pharmaceutical manufacturers, process skid OEMs, and sanitary mechanical contractors across the U.S., cultivating high-level industry relationships and expanding business opportunities.

A recognized thought leader, Collentro has contributed to the International Society of Pharmaceutical Engineering (ISPE) Baseline and several Good Practice Guides, served as a steering committee member and past chair of the ISPE Critical Utilities Community of Practice, and holds multiple U.S. patents related to high-purity water production. As a faculty member of the ISPE Training Institute and an internationally recognized speaker, he has delivered over 100 technical presentations and published extensively in industry journals.

Jason Teets, PCI’s New England Branch general manager, said, “We are thrilled to welcome Andrew to the team. His extensive industry experience and business expertise will help us better serve our clients and anticipate their evolving needs. His understanding of the life sciences industry and commitment to client success align perfectly with PCI’s values, and we’re excited to see him drive new opportunities for our cleanroom solutions.”

Sean Marrie, director of business development at PCI, said, “Andrew’s strong industry relationships and ability to navigate the complexities of our industry’s business development make him an excellent addition to our team. His strategic mindset and deep connections with key decision-makers will be instrumental in expanding our presence in the life sciences sector and positioning PCI for long-term growth.”

At PCI, Collentro will focus on strengthening partnerships, expanding business opportunities, and enhancing the firm’s position as a trusted provider of advanced cleanroom solutions for pharmaceutical manufacturing.

For more information, visit PCI New England’s resource page.